According to a recently published report by Roots Analysis, the increasing prevalence of chronic pain and growing demand for drug-free pain interventions is driving the pain management devices market growth
The global pain management devices market size is expected to reach over USD 13.32 billion by 2035, growing at a CAGR of ~5% during the forecast period, 2024-2035.
Pain is a multisensory experience, which may have neurophysiological, biochemical, psychological, ethnocultural, cognitive and environmental causes that eventually lead to physiological, anatomical, and behavioral changes. The prevalence of pain is substantial, impacting a significant number of individuals globally. For instance, in the US, 21% of adults suffer from chronic pain, while 8% suffer from high impact chronic pain. Given its significant prevalence, effective pain management is crucial to address this widespread issue. Pain management typically involves the deployment of pharmacological measures (such as analgesics, antidepressants and anticonvulsants) and devices (such as neurostimulation devices, ablation devices, infusion pump and virtual reality devices). Notably, pain management devices offer several advantages over traditional pharmacological methods; these include localized pain relief without systemic side effects, reduced dependency on pain medications, better treatment options and improved quality of life. Driven by rising prevalence of chronic pain indications and growing demand for non-pharmacological interventions, the pain management devices market is anticipated to witness substantial growth in the foreseeable future.
Browse 115+ figures and 115+ market data tables spread across 130+ pages and detailed Table of Content on “Pain Management Devices Market by Type of Pain Management Device, Type of Neurostimulation Device, Application Area, Modes of Purchase, End User and Geographical Regions: Industry Trends and Global Forecasts, till 2035” here: https://www.rootsanalysis.com/reports/pain-management-devices-market.html
Several factors are propelling the pain management devices market growth. Growing geriatric population, lifestyle habits and the rising incidence of chronic diseases have led to the growing prevalence of chronic pain conditions, such as arthritis and diabetic neuropathy, which demand effective and long-term treatment solutions. This has spurred the need for pain management devices. Additionally, increased research and development initiatives, such as NIH HEAL initiative, to develop novel patient-centric devices, is significantly driving the market. These efforts accelerate the discovery and development of advanced devices, enhancing the range of available treatment options as well as the patient outcomes. As a result, the pain management devices market is expected to witness substantial growth in the foreseeable future.
While the pain management devices market is experiencing substantial growth, it is not without its challenges. One of the primary restraints is the high cost associated with the devices available for pain management which limits the patient’s access, especially those without health insurance or living in underdeveloped regions. This financial burden has a ripple effect, impacting both individuals and healthcare systems by straining healthcare budgets. Moreover, varying regulatory requirements across the regions can lead to delays in the approval of pain management devices, hindering equal access to the benefits of these treatment options.
Despite the challenges, several growth factors continue to drive the global pain management devices market forward. One notable factor is the increasing awareness and acceptance of non-opioid pain management therapies. Moreover, opioid crisis has prompted both the patients and healthcare providers to seek safer alternatives for pain relief. It is worth mentioning that AI is revolutionizing pain prediction and personalized treatment outcomes. The AI algorithms can analyze large datasets to forecast pain occurrences based on personal health records, ultimately improving the efficacy of pain relief devices and making the devices more precise. Furthermore, the introduction of virtual reality devices, which have the ability to divert attention from pain through rich sensory experiences, is also anticipated to transform the landscape of pain management.
The pain management devices market report also includes profiles of key players (listed below) that are engaged in the development of pain management:
Abbott, AppliedVR, AtriCure, Avanos Medical, Becton, Dickinson and Company, BioElectronics, Hexainnoheal, Litemed, Medtronic, Micrel Medical Devices, Nalu Medical, Nevro, Smileyscope, Stryker, ZetrOZ Systems, Zynex Medical
You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/pain-management-devices-market/request-sample.html
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner
SUBSCRIBE TO INDUSTRY UPDATES